Crossmark

Comparison of regional citrate anticoagulation and nafamostat mesylate anticoagulation during plasma exchange for children at high bleeding risk: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s13052-025-01954-4

Published Online: 2025-04-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peng, Dan

Cai, Zili

He, Jie

Duan, Wei

Zhang, Xinping https://orcid.org/0000-0002-7167-0031
Funding

Funding for this research was provided by:

Health Commission of Hunan Province Scientific Research Plan Project (C202306018490, 202206013996)

Hunan Province Science and Technology Innovation Plan Project (2021SK50524)
License Information

Text and Data Mining valid from 2025-04-12

Version of Record valid from 2025-04-12
More Information

Article History

Received: 8 July 2024

Accepted: 27 March 2025

First Online: 12 April 2025

Declarations

:

: This study was approved by the Ethics Committee of Hunan Children’s Hospital (Ethics No.: HCHLL-2024-269). The requirement for informed consent was waived owing to the retrospective observational study design, involving data extracted from the electronic medical record system without involving patient privacy or commercial interests. All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below